307
Views
0
CrossRef citations to date
0
Altmetric
Original Article

CMV Retinitis in Wiskott Aldrich Syndrome

, MD, , MD, , MDORCID Icon & , MD, PhDORCID Icon
Pages 134-141 | Received 10 Aug 2021, Accepted 14 Oct 2021, Published online: 08 Dec 2021

References

  • Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133–139.
  • Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J Clin Immunol. 2018;38(1):13–27. doi:10.1007/s10875-017-0453-z.
  • Perry GS 3rd, Spector BD, Schuman LM, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr. 1980;97(1):72–78. doi:10.1016/S0022-3476(80)80133-8.
  • Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78(4):635–644. doi:10.1016/0092-8674(94)90528-2.
  • Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European society for immunodeficiencies and European group for blood and marrow transplantation. Blood. 2008;111(1):439–445. doi:10.1182/blood-2007-03-076679.
  • Parkman R, Rappeport J, Geha R, et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978;298(17):921–927. doi:10.1056/NEJM197804272981701.
  • Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011;118(6):1675–1684. doi:10.1182/blood-2010-11-319376.
  • Rai R, Romito M, Rivers E, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich syndrome. Nat Commun. 2020;11(1):4034. doi:10.1038/s41467-020-17626-2.
  • Radwan A, Metzinger JL, Hinkle DM, Foster CS. Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm. 2013;21(4):324–328. doi:10.3109/09273948.2013.786095.
  • Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008;10(1):13–18. doi:10.1111/j.1399-3062.2007.00241.x.
  • Almagor Y, Revel-Vilk S, Averbuch D, et al. Congenital cytomegalovirus infection and Wiskott-Aldrich syndrome successfully treated with unrelated cord blood transplantation. Pediatr Blood Cancer. 2011;57(4):681–683. doi:10.1002/pbc.23056.
  • Gore SK, Gore DM, Chetty K, Visser L. Cytomegaloviral retinitis-related retinal detachment: outcomes following vitrectomy in the developing world. Int Ophthalmol. 2014;34(2):205–210. doi:10.1007/s10792-013-9814-7.
  • Holland GN, Vaudaux JD, Jeng SM, et al. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol. 2008;145(1):5–11. doi:10.1016/j.ajo.2007.09.023.
  • Tadepalli S, Bajgai P, Dogra M, et al. Ultra-widefield fundus autofluorescence in cytomegalovirus retinitis. Ocul Immunol Inflamm. 2020;28(3):446–452. doi:10.1080/09273948.2019.1595671.
  • Spaide RF, Vitale AT, Toth IR, Oliver JM. Frosted branch angiitis associated with cytomegalovirus retinitis. Am J Ophthalmol. 1992;113(5):522–528. doi:10.1016/S0002-9394(14)74723-3.
  • Kaushik S, Singh R, Gupta A, et al. Unilateral recalcitrant glaucoma associated with cytomegalovirus in an immunocompromised child with Wiskott-Aldrich syndrome. J AAPOS. 2013;17(6):646–647. doi:10.1016/j.jaapos.2013.08.007.
  • Port AD, Orlin A, Kiss S, et al. Cytomegalovirus retinitis: a review. J Ocul Pharmacol Ther. 2017;33(4):224–234. doi:10.1089/jop.2016.0140.
  • Martin DF, Sierra-Madero J, Walmsley S, et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med. 2002;346(15):1119–1126. doi:10.1056/NEJMoa011759.
  • Thrasher AJ. WASp in immune-system organization and function. Nat Rev Immunol. 2002;2(9):635–646. doi:10.1038/nri884.
  • Bouma G, Burns SO, Thrasher AJ. Wiskott-Aldrich syndrome: immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology. 2009;214(9–10):778–790. doi:10.1016/j.imbio.2009.06.009.
  • Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International bone marrow transplant registry and the national marrow donor program. Blood. 2001;97(6):1598–1603. doi:10.1182/blood.V97.6.1598.
  • Worth AJ, Thrasher AJ. Current and emerging treatment options for Wiskott-Aldrich syndrome. Expert Rev Clin Immunol. 2015;11(9):1015–1032. doi:10.1586/1744666X.2015.1062366.
  • Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2003;101(2):407–414. doi:10.1182/blood-2002-03-0993.
  • Zhang ZY, Xiao HQ, Jiang LP, et al. Analysis of clinical and molecular characteristics of Wiskott-Aldrich syndrome in 24 patients from 23 unrelated Chinese families. Pediatr Allergy Immunol. 2010;21(3):522–532. doi:10.1111/j.1399-3038.2010.00996.x.
  • Richter D, Hampl W, Pohlandt F. Vertical transmission of cytomegalovirus, most probably by breast milk, to an infant with Wiskott-Aldrich syndrome with fatal outcome. Eur J Pediatr. 1997;156(11):854–855. doi:10.1007/s004310050729.
  • Crippa F, Corey L, Chuang EL, Sale G, Boeckh M. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32(2):214–219. doi:10.1086/318447.
  • Xhaard A, Robin M, Scieux C, et al. Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation. Transplantation. 2007;83(1):80–83. doi:10.1097/01.tp.0000239512.94181.e9.
  • Jeon S, Lee WK, Lee Y, Lee DG, Lee JW. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology. 2012;119(9):1892–1898. doi:10.1016/j.ophtha.2012.03.032.
  • Zöllner SK, Herbrüggen H, Kolve H, et al. Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2019;21(5):e13089. doi:10.1111/tid.13089.
  • Hiwarkar P, Gajdosova E, Qasim W, et al. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis. 2014;58(12):1700–1706. doi:10.1093/cid/ciu201.
  • Matos K, Muccioli C, Belfort Junior R, Rizzo LV. Correlation between clinical diagnosis and PCR analysis of serum, aqueous, and vitreous samples in patients with inflammatory eye disease. Arq Bras Oftalmol. 2007;70(1):109–114. doi:10.1590/S0004-27492007000100020.
  • Smith IL, Macdonald JC, Freeman WR, Shapiro AM, Spector SA. Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous. J Infect Dis. 1999;179(5):1249–1253. doi:10.1086/314710.
  • Celiker H, Karaaslan A, Kepenekli Kadayifci E, et al. Cytomegalovirus retinitis in an ALL child during maintenance therapy treated successfully with intravenous ganciclovir. Case Rep Ophthalmol Med. 2014;2014:294238.
  • Du KF, Huang XJ, Chen C, et al. High blood cytomegalovirus load suggests cytomegalovirus retinitis in HIV/AIDS patients: a cross-sectional study. Ocul Immunol Inflamm. 2021:1–5. doi:10.1080/09273948.2021.1905857.
  • Mori T, Kato J. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int J Hematol. 2010;91(4):588–595. doi:10.1007/s12185-010-0569-x.
  • Paulin T, Ringdén O, Lönnqvist B, Wahren B, Nilsson B. The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors. Scand J Infect Dis. 1986;18(3):199–209.doi:10.3109/00365548609032328.
  • Heiden D, Tun N, Smithuis FN, et al. Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019;103(2):157–160. doi:10.1136/bjophthalmol-2018-312406.
  • Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997;349(9063):1443–1445. doi:10.1016/S0140-6736(96)11431-8.
  • Holland GN. Immune recovery uveitis. Ocul Immunol Inflamm. 1999;7(3–4):215–221. doi:10.1076/ocii.7.3.215.4010.
  • Baker ML, Allen P, Shortt J, Lewin SR, Spencer A. Immune recovery uveitis in an HIV-negative individual. Clin Exp Ophthalmol. 2007;35(2):189–190. doi:10.1111/j.1442-9071.2006.01439.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.